Quince Therapeutics Advances Trials on EryDex
by Denny Jacob Quince Therapeutics announced its plans to move forward with trials on EryDex after the U.S. Food and Drug Administration (FDA) lifted the hold on EryDel's investigational new…
FDA Issues Warning Letter to Infant-Formula Makers
The U.S. Food and Drug Administration (FDA) has recently sent a warning letter to three infant-formula makers, urging them to improve their safety protocols to prevent contamination. The recipients of…